Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Janssen Biotech patents new antibodies targeting human TF

Oct. 9, 2012

Kissei Pharmaceutical synthesizes new D2 receptor agonists

Oct. 9, 2012

Ludwig Institute for Cancer Research discloses novel TbetaR-I blocking antibodies

Oct. 9, 2012

Novel anticancer oligopeptides patented by CSIR

Oct. 9, 2012

Researchers in Thailand synthesize novel dihydrofolate reductase inhibitors

Oct. 8, 2012

Locus Pharmaceuticals patents new ITK inhibitors

Oct. 8, 2012

Industrial Research and University of Liverpool disclose novel BACE1 inhibitors

Oct. 8, 2012

Novel agents for diabetes prepared by Danish group

Oct. 8, 2012

Allergan presents new FPRL1 receptor ligands

Oct. 8, 2012

National Institute of Biomedical Innovation patents new antibodies for cancer

Oct. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026